(Date:1/9/2009)..., KALAMAZOO, Mich., Jan. 9 /PRNewswire-FirstC...ced today that net sales were $1,718 million for t...crease over net sales of $1,658 million,for the f... the year ended,December 31, 2008, representing a...for the year ended December 31, 2007. On a consta...
(Date:1/9/2009)..., Solutions to tomorrow,s (and even today,s) heal...nd gadgets at the 2009 Consumer Electronics Show ,... -- We have become accustomed to technology chang...y in touch with our friends and family. However, m...ning, stressful, and challenging experience for mi...
(Date:1/9/2009)...urvey found mismatch between perception, reality ,...rents may not always be the best barometer of thei...shows. , Researchers reported in the January/Fe...d Behavior that mothers of preschool-aged childre... those with older children did not. But when the c...
(Date:1/9/2009)...ong-term study says the drugs should only be used ...an. 9 (HealthDay News) -- Alzheimer,s patients who...risk of death than similar patients not given thes... While the short-term use of antipsychotics has be...have found that prolonged use can have serious sid...
Breaking Medicine News(10 mins):Health News:Stryker Updates Expected 2008 Results and Provides 2009 Outlook 2Health News:Stryker Updates Expected 2008 Results and Provides 2009 Outlook 3Health News:Stryker Updates Expected 2008 Results and Provides 2009 Outlook 4Health News:Meridian Makes CES Good For Your Health 2Health News:Parents Not Best Barometer of Kid's Eating, Exercise Habits 2Health News:Antipsychotics Up Death Risk in Alzheimer's Patients 2Health News:Antipsychotics Up Death Risk in Alzheimer's Patients 3...Fraud Services (CFS) investigating illegal claims ...the grip on health service frauds.// The frauds ra... dentists failing to put enough gold in patients' ...e theft of prescriptions, which netted him ?120,00...
...r-old schoolboy in Bihar lost his life when some s...nd he fell hitting his head// on the floor. Qamar ...n Darbhanga district's Manihas village, died Thurs...rcibly pushed off the bench by students in a fight...
...d, from Bloxwich in Walsall, was wrongly diagnosed...His stomach was removed. Much later, it was found ... tests and Mr. Ford had only a benign tumor. The o...02 at Walsall Manor Hospital. The pathologist resp...
...are circumcised are less likely to contract HIV th...arch presented recently at the International AIDS ...l men are at least 60 percent less likely to contr...cised counterparts, reported the online edition of...
Other Medicine News:(Date:1/7/2009)...ERICK, Md., Jan. 7 ImQuest Life Sc...f an IND application to the Food and Drug Administ... lead pyrimidinedione HIV inhibitor IQP-0410. ImQu...n the first quarter of 2009. IQP-0410 is a novel s...s as a nonnucleoside reverse transcriptase inhibit...
(Date:1/6/2009)...es significance of AHCC for maintaining a healthy ...swire/ -- A recently published study in Nutrition...nsai Medical University in Osaka, Japan has shown ...nces immune function by increasing the number of d...mune system responsible for presenting foreign sub...
(Date:1/6/2009)...PARSIPPANY, N.J., Jan. 6 Pacira Ph...maceutical company, announced today that enrollmen...PLE trials to evaluate the,safety and efficacy of...(TM),(DepoBupivacaine) for prolonged postoperativ...hemorrhoidectomy and in total knee,arthroplasty (...
(Date:1/3/2009)... , , , ROSEMONT, Ill., Jan. 2 /PR... (MRI) is a growing technology providing an increa...evaluation of back pain according to an article in...ican Academy of Orthopaedic Surgeons ( http://www....several years, additional technical developments w...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3UIC chemists characterize Alzheimers neurotoxin structure 7426 1UIC chemists characterize Alzheimers neurotoxin structure 7426 2ESi Announces Strategic New Hire in Boston 7424 1ESi Announces Strategic New Hire in Boston 7424 2Leading Epilepsy Groups Unveil New Survey Results Challenging Patients to Take Charge of Their Health 7421 1Leading Epilepsy Groups Unveil New Survey Results Challenging Patients to Take Charge of Their Health 7421 2Leading Epilepsy Groups Unveil New Survey Results Challenging Patients to Take Charge of Their Health 7421 3Leading Epilepsy Groups Unveil New Survey Results Challenging Patients to Take Charge of Their Health 7421 4ReBuilder Medical Technologies Inc Reports Doubled Profits for October 7418 1ReBuilder Medical Technologies Inc Reports Doubled Profits for October 7418 2...4, 2007 - Cougar Biotechnology,Inc. (OTCBB: CGRB)... Phase II data on the Company,s prostate cancer dr...ented at the American Society,of Clinical Oncology...place in Chicago, Illinois. The data was presented..., as part of the poster,discussion session for gen...
...--Jun 4, 2007 - GenVec, Inc.,(Nasdaq: GNVC) announ...cacy data from the clinical development program of...poster session on,gastrointestinal cancers at the ...cology in Chicago, IL by Dr. Mitchell Posner, of t...e posters then,concluded the Saturday morning view...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 6GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 2GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 3GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 4